| Metric | FY2026 | FY2025 | FY2024 |
|---|---|---|---|
| Revenue | $709.0M+31.7% | $538.3M+32.3% | $406.9M |
| Cost of revenue | $226.3M+18.9% | $190.4M+16.3% | $163.6M |
| Gross profit | $482.7M+38.7% | $347.9M+43.0% | $243.3M |
| Sales and marketing | $393.7M+40.2% | $280.8M+6.7% | $263.1M |
| Research and development | $509.0M+100.3% | $254.2M+13.2% | $224.5M |
| General and administrative | $232.5M+238.8% | $68.6M+0.2% | $68.5M |
| Total operating expenses | $1.14B+88.1% | $603.6M+8.6% | $556.0M |
| Loss from operations | -$652.6M-155.2% | -$255.7M+18.2% | -$312.8M |
| Loss on changes in fair value of convertible notes | -$34.3M+65.3% | -$98.6M-155.7% | -$38.6M |
| Other income, net | $18.8M+358.0% | $4.1M-69.2% | $13.3M |
| Loss before provision for income taxes | -$668.1M-90.7% | -$350.3M-3.6% | -$338.1M |
| Provision for income taxes | $11.3M+167.1% | $4.2M-37.5% | $6.8M |
| Net loss | -$679.4M-91.6% | -$354.5M-2.8% | -$344.9M |
| Net loss per share attributable to common stockholders, basic | -$3.18+12.6% | -$3.64+3.4% | -$3.77 |
| Net loss per share attributable to common stockholders, diluted | -$3.18+12.6% | -$3.64+3.4% | -$3.77 |
| Weighted-average shares used in computing net loss per share attributable to common stockholders, basic | $213896041.00+119.3% | $97515591.00+6.7% | $91394561.00 |
| Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted | $213896041.00+119.3% | $97515591.00+6.7% | $91394561.00 |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.